Skip to main content
    S

    STERIS plc (STE)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $262.05
    -2.27 (-0.86%)

    Market Cap: $25.67B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    STERIS plc (STE) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect STERIS (STE) to earn $11.41 per share in the fiscal year ending Mar 31, 2027, on revenue of $6.37B. Of 8 analysts, 5 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Mar 31, 2028, the EPS consensus is $12.38.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.25, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 63% of the ratings.

    RatingAnalystsShare
    Strong Buy112.5%
    Buy450.0%
    Hold337.5%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    8

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 8.5% and revenue estimates rise 6.6%.

    Fiscal year ending Mar 31, 2027
    $11.41
    EPS consensus, revenue $6.37B
    Fiscal year ending Mar 31, 2028
    $12.38
    EPS consensus, revenue $6.79B
    Next report
    Feb 2, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Mar 31, 2027$11.41$11.19 to $11.478$6.37B$6.36B to $6.39B8
    Mar 31, 2028$12.38$12.04 to $12.588$6.79B$6.68B to $6.96B8

    Quarterly Estimates

    The EPS consensus rises from $2.80 for the quarter ending Dec 31, 2026 to $3.18 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.80$2.78 to $2.837$1.60B$1.59B to $1.61B7
    Mar 31, 2027$3.18$3.07 to $3.349$1.71B$1.57B to $1.84B9

    Estimate Revisions

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Mar 31, 202810

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Mar 31, 2027 has risen 2.2% from $11.16.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Mar 31, 2027$11.41$11.20$11.17$11.17$11.16+2.3%
    Fiscal year ending Mar 31, 2028$12.38$12.33$12.25$12.25$12.24+1.2%
    Quarter ending Dec 31, 2026$2.80$2.80$2.81$2.81$2.81-0.4%

    Frequently Asked Questions About STE

    What is the STE stock forecast?

    Consensus analyst estimates put STERIS's EPS at $11.41 for the fiscal year ending Mar 31, 2027, on revenue of $6.37B. The consensus rating from 8 analysts is Buy.

    How do analysts rate STE stock?

    Of 8 analysts covering STERIS, 1 rates it Strong Buy, 4 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from STE next year?

    For the fiscal year ending Mar 31, 2027, the consensus EPS estimate is $11.41, with estimates from $11.19 to $11.47 from 8 analysts. For the fiscal year ending Mar 31, 2028, the consensus EPS estimate is $12.38, with estimates from $12.04 to $12.58 from 8 analysts.

    What revenue do analysts expect from STERIS next year?

    For the fiscal year ending Mar 31, 2027, the consensus revenue estimate is $6.37B, with estimates from $6.36B to $6.39B. For the fiscal year ending Mar 31, 2028, the consensus revenue estimate is $6.79B, with estimates from $6.68B to $6.96B.

    How many analysts cover STE?

    8 analysts rate STERIS stock, and 8 analysts estimate its EPS for the fiscal year ending Mar 31, 2027.